R. Kerry Clark
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
General Mills Highlighted in Dividend Stock Comparisons. Several Yahoo articles compared General Mills’ dividend yield of 3.62% to other food giants such as Hershey, PepsiCo, and Tyson Foods. The pieces noted that while General Mills’ yield is below some peers, analysts still project a target price of $37.00. The stock sits near its 9‑touch support level of $34.03 and has a neutral RSI of 43.1. These comparisons may influence how dividend‑focused investors view the company.
Transaction History
| TXT | ▼ Sell | Open Market | 2,517 | $234K | 5/6/2026 | View on chart |
| TXT | ▲ Buy | Grant | 2,061 | $0 | 4/29/2026 | View on chart |
| ELV | ▲ Buy | Grant | 601 | $0 | 5/14/2025 | View on chart |
| TXT | ▲ Buy | Grant | 2,794 | $0 | 4/23/2025 | View on chart |
| ELV | ▲ Buy | Grant | 388 | $0 | 5/15/2024 | View on chart |
| TXT | ▲ Buy | Grant | 1,756 | $0 | 4/24/2024 | View on chart |
| TXT | ▼ Sell | Open Market | 9,353 | $702K | 10/27/2023 | View on chart |
| GIS | ▲ Buy | Grant | 2,760 | $0 | 9/26/2023 | View on chart |
| TXT | ▼ Sell | Open Market | 5,000 | $377K | 8/22/2023 | View on chart |
| ELV | ▲ Buy | Grant | 457 | $0 | 5/10/2023 | View on chart |
| TXT | ▲ Buy | Grant | 2,517 | $0 | 4/26/2023 | View on chart |
| GIS | ▲ Buy | Grant | 2,309 | $0 | 9/27/2022 | View on chart |
| ELV | ▲ Buy | Grant | 440 | $0 | 5/18/2022 | View on chart |
| TXT | ▲ Buy | Grant | 2,174 | $0 | 4/27/2022 | View on chart |
| GIS | ▲ Buy | Grant | 3,034 | $0 | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Textron Q3 2026 Earnings Preview and Industry News
Investors are focusing on Textron's upcoming Q3 2026 earnings report, which is a key upcoming event for the company. Recent news also highlights broader defense sector developments, including a major amphibious vehicle deal for a competitor and new Pentagon drone initiatives. These industry updates provide context for Textron's position in the aerospace and defense market ahead of its financial results.
Textron Q3 2026 Earnings Preview and Industry News. Investors are focusing on Textron's upcoming Q3 2026 earnings report, which is a key upcoming event for the company. Recent news also highlights broader defense sector developments, including a major amphibious vehicle deal for a competitor and new Pentagon drone initiatives. These industry updates provide context for Textron's position in the aerospace and defense market ahead of its financial results.